Cargando…

A study on the association of serum fibroblast growth factor-23 with various indices of chronic kidney disease patients not yet on dialysis

Introduction: Fibroblast growth factor-23 (FGF23) is found as a bone derived hormone which can influence the serum levels of parathormone, phosphorous and 1, 25-dihydroxyvitamin D. FGF23 may be a cardiovascular biomarker in patients with chronic kidney disease (CKD). While, FGF23 is inversely correl...

Descripción completa

Detalles Bibliográficos
Autores principales: Yaghoubi, Fatemeh, Ahmadi, Farrokhleghah, Lesanpezeshki, Mahboub, Mahdavi Mazde, Mitra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nickan Research Institute 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962669/
https://www.ncbi.nlm.nih.gov/pubmed/27471744
http://dx.doi.org/10.15171/jrip.2016.22
_version_ 1782444867794763776
author Yaghoubi, Fatemeh
Ahmadi, Farrokhleghah
Lesanpezeshki, Mahboub
Mahdavi Mazde, Mitra
author_facet Yaghoubi, Fatemeh
Ahmadi, Farrokhleghah
Lesanpezeshki, Mahboub
Mahdavi Mazde, Mitra
author_sort Yaghoubi, Fatemeh
collection PubMed
description Introduction: Fibroblast growth factor-23 (FGF23) is found as a bone derived hormone which can influence the serum levels of parathormone, phosphorous and 1, 25-dihydroxyvitamin D. FGF23 may be a cardiovascular biomarker in patients with chronic kidney disease (CKD). While, FGF23 is inversely correlated with serum adiponectin level, thus it is possible that FGF23 is correlated to fat mass and related to dyslipidemia in CKD. Objectives: In this investigation, we studied the association of serum levels of FGF23 with serum lipid profile, body mass index (BMI), and various cardiovascular risk factors in patients with CKD. Patients and Methods: This is a cross-sectional study, which was conducted on 80 non-dialysis patients (glomerular filtration rate [GFR] <60 cc/min) with CKD. Laboratory results and demographic information recorded in pre-defined data sheets and their relationship with FGF23 were analyzed. Results: Eighty patients were studied. Mean ± standard deviation (SD) of serum creatinine and FGF23 were 2.18 ± 0.73 mg/dl and 15.028 ± 20.20 RU/ml respectively. The correlation between FGF23, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), ApoA, ApoB, intact parathyroid hormone (iPTH), calcium, phosphorous, alkaline phosphatase, 25-hydroxyvitamin D, BMI, waist girth, serum triglyceride and cholesterol was not significant (P > 0.05). In this study, the correlations of FGF23, with serum albumin (P = 0.036) and systolic blood pressure (P = 0.001) were significant. Conclusion: Our study showed that there are not any significant correlations among FGF23, BMI and lipid profile. There are not any significant correlations between FGF23 and age, sex, and level of calcium, phosphorous, vitamin D. However, the relationships between FGF23 and serum albumin was negatively significant. Additionally we detected a positive significant correlation of FGF23 with level of systolic blood presure.
format Online
Article
Text
id pubmed-4962669
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nickan Research Institute
record_format MEDLINE/PubMed
spelling pubmed-49626692016-07-28 A study on the association of serum fibroblast growth factor-23 with various indices of chronic kidney disease patients not yet on dialysis Yaghoubi, Fatemeh Ahmadi, Farrokhleghah Lesanpezeshki, Mahboub Mahdavi Mazde, Mitra J Renal Inj Prev Original Article Introduction: Fibroblast growth factor-23 (FGF23) is found as a bone derived hormone which can influence the serum levels of parathormone, phosphorous and 1, 25-dihydroxyvitamin D. FGF23 may be a cardiovascular biomarker in patients with chronic kidney disease (CKD). While, FGF23 is inversely correlated with serum adiponectin level, thus it is possible that FGF23 is correlated to fat mass and related to dyslipidemia in CKD. Objectives: In this investigation, we studied the association of serum levels of FGF23 with serum lipid profile, body mass index (BMI), and various cardiovascular risk factors in patients with CKD. Patients and Methods: This is a cross-sectional study, which was conducted on 80 non-dialysis patients (glomerular filtration rate [GFR] <60 cc/min) with CKD. Laboratory results and demographic information recorded in pre-defined data sheets and their relationship with FGF23 were analyzed. Results: Eighty patients were studied. Mean ± standard deviation (SD) of serum creatinine and FGF23 were 2.18 ± 0.73 mg/dl and 15.028 ± 20.20 RU/ml respectively. The correlation between FGF23, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), ApoA, ApoB, intact parathyroid hormone (iPTH), calcium, phosphorous, alkaline phosphatase, 25-hydroxyvitamin D, BMI, waist girth, serum triglyceride and cholesterol was not significant (P > 0.05). In this study, the correlations of FGF23, with serum albumin (P = 0.036) and systolic blood pressure (P = 0.001) were significant. Conclusion: Our study showed that there are not any significant correlations among FGF23, BMI and lipid profile. There are not any significant correlations between FGF23 and age, sex, and level of calcium, phosphorous, vitamin D. However, the relationships between FGF23 and serum albumin was negatively significant. Additionally we detected a positive significant correlation of FGF23 with level of systolic blood presure. Nickan Research Institute 2016-04-22 /pmc/articles/PMC4962669/ /pubmed/27471744 http://dx.doi.org/10.15171/jrip.2016.22 Text en Copyright © 2016 The Author(s); Published by Nickan Research Institute http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Yaghoubi, Fatemeh
Ahmadi, Farrokhleghah
Lesanpezeshki, Mahboub
Mahdavi Mazde, Mitra
A study on the association of serum fibroblast growth factor-23 with various indices of chronic kidney disease patients not yet on dialysis
title A study on the association of serum fibroblast growth factor-23 with various indices of chronic kidney disease patients not yet on dialysis
title_full A study on the association of serum fibroblast growth factor-23 with various indices of chronic kidney disease patients not yet on dialysis
title_fullStr A study on the association of serum fibroblast growth factor-23 with various indices of chronic kidney disease patients not yet on dialysis
title_full_unstemmed A study on the association of serum fibroblast growth factor-23 with various indices of chronic kidney disease patients not yet on dialysis
title_short A study on the association of serum fibroblast growth factor-23 with various indices of chronic kidney disease patients not yet on dialysis
title_sort study on the association of serum fibroblast growth factor-23 with various indices of chronic kidney disease patients not yet on dialysis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962669/
https://www.ncbi.nlm.nih.gov/pubmed/27471744
http://dx.doi.org/10.15171/jrip.2016.22
work_keys_str_mv AT yaghoubifatemeh astudyontheassociationofserumfibroblastgrowthfactor23withvariousindicesofchronickidneydiseasepatientsnotyetondialysis
AT ahmadifarrokhleghah astudyontheassociationofserumfibroblastgrowthfactor23withvariousindicesofchronickidneydiseasepatientsnotyetondialysis
AT lesanpezeshkimahboub astudyontheassociationofserumfibroblastgrowthfactor23withvariousindicesofchronickidneydiseasepatientsnotyetondialysis
AT mahdavimazdemitra astudyontheassociationofserumfibroblastgrowthfactor23withvariousindicesofchronickidneydiseasepatientsnotyetondialysis
AT yaghoubifatemeh studyontheassociationofserumfibroblastgrowthfactor23withvariousindicesofchronickidneydiseasepatientsnotyetondialysis
AT ahmadifarrokhleghah studyontheassociationofserumfibroblastgrowthfactor23withvariousindicesofchronickidneydiseasepatientsnotyetondialysis
AT lesanpezeshkimahboub studyontheassociationofserumfibroblastgrowthfactor23withvariousindicesofchronickidneydiseasepatientsnotyetondialysis
AT mahdavimazdemitra studyontheassociationofserumfibroblastgrowthfactor23withvariousindicesofchronickidneydiseasepatientsnotyetondialysis